Congoleum Cushioned Vinyl Flooring

Product Description

Congoleum Corporation was one of the United States’ most prominent manufacturers of resilient flooring products throughout much of the twentieth century. Among its product lines, cushioned vinyl flooring held a central place in both residential and commercial markets. Marketed for its comfort underfoot, durability, and ease of installation and maintenance, cushioned vinyl was a widely adopted flooring solution in homes, hospitals, schools, office buildings, and industrial facilities across the country.

Congoleum’s cushioned vinyl products were sheet flooring goods, meaning they were manufactured and sold in large rolls rather than as individual tiles. The “cushioned” designation referred to a foam or felt backing layer laminated beneath the vinyl wear surface, which gave the flooring its characteristic resilience and sound-dampening properties. This multi-layer construction—combining a decorative vinyl surface, a foam or backing layer, and often a felt or fibrous underlayer—was produced through industrial calendering and lamination processes at Congoleum’s manufacturing facilities.

The product achieved broad market penetration during the mid-to-late twentieth century, when resilient flooring of all types was a standard feature of new construction and renovation projects. Because sheet flooring was sold in continuous rolls, it was often installed in large commercial and industrial spaces as well as in residential kitchens, bathrooms, and utility areas. Congoleum promoted its cushioned vinyl products under various trade names and patterns over the decades, making the brand a recognizable name in the flooring industry.

Asbestos Content

Litigation records document that Congoleum’s cushioned vinyl flooring products contained asbestos as a component of their construction during certain periods of production. Plaintiffs alleged that asbestos fibers were incorporated into the backing, felt underlayer, or other fibrous components of the sheet flooring, consistent with industry-wide practices during eras when asbestos was routinely added to resilient flooring products for its reinforcing, fire-resistant, and dimensional-stability properties.

Asbestos mineral fibers—most commonly chrysotile, though other amphibole varieties were also documented in flooring industry applications—were blended into backing materials or felt layers that formed the structural foundation of cushioned sheet flooring. Plaintiffs alleged that these fibers were present throughout the product’s lifespan: during manufacture, during installation, and critically, during maintenance and removal activities when the flooring was disturbed, cut, or abraded.

Litigation records further document that Congoleum was aware, or should have been aware, of the hazards associated with asbestos in its products during relevant periods, and that the company did not adequately warn workers or consumers about these risks. The specific formulations and asbestos concentrations varied across product lines and manufacturing periods, but the presence of asbestos in at least some Congoleum cushioned vinyl products has been a documented subject of civil litigation.

How Workers Were Exposed

Industrial workers generally represent the population most heavily documented in litigation involving Congoleum cushioned vinyl flooring. Exposure pathways were multiple and occurred across the product’s full lifecycle.

Manufacturing workers employed at Congoleum production facilities were potentially exposed during the blending, calendering, and lamination processes used to manufacture the flooring. Handling raw asbestos-containing materials, operating mixing equipment, and working in environments where asbestos-laden dust could become airborne all represented documented exposure pathways for plant employees.

Flooring installers and tradespeople faced exposure when working with the sheet flooring in the field. Cutting cushioned vinyl to fit room dimensions with knives or shears, scoring the material, and trimming edges could release fibers from asbestos-containing backing layers. Plaintiffs alleged that this cutting process—a routine and unavoidable part of installation—was a primary mechanism of fiber release during normal work activities.

Maintenance and renovation workers encountered significant exposure risks when existing Congoleum cushioned vinyl flooring was disturbed. Removing old sheet flooring—particularly when it had been adhesively bonded to subfloors—required scraping, grinding, or otherwise abrading the material. These activities were alleged to release substantially higher concentrations of asbestos fibers than initial installation, because aged and brittle backing materials tended to fragment and powder more readily than intact new flooring.

Industrial facility workers in plants and manufacturing environments where Congoleum cushioned vinyl had been installed as flooring material could also have been exposed secondarily if the flooring was damaged, worn, or disturbed by routine industrial operations such as forklift traffic, heavy equipment movement, or floor cleaning activities that abraded the surface and backing.

Litigation records document that workers in these categories often labored without respiratory protection or adequate ventilation, and without knowledge that the flooring materials they were handling contained asbestos. OSHA’s current permissible exposure limit for asbestos is 0.1 fibers per cubic centimeter of air as an eight-hour time-weighted average, with a short-term excursion limit of 1.0 fiber per cubic centimeter over a thirty-minute period. The disturbance of asbestos-containing resilient flooring backing materials has been documented to generate fiber concentrations that can exceed these thresholds without appropriate controls.

The latency period for asbestos-related diseases—typically ranging from ten to fifty years between first exposure and clinical diagnosis—means that workers exposed to Congoleum cushioned vinyl during peak installation and renovation periods from the mid-twentieth century forward may be receiving diagnoses today or in coming years.

Congoleum Corporation itself has been the subject of asbestos-related bankruptcy proceedings. The company filed for Chapter 11 bankruptcy protection in part to address the substantial volume of asbestos liability claims brought against it. As a result of those proceedings, legal remedies for individuals harmed by Congoleum asbestos-containing products are pursued primarily through civil litigation channels, as a fully resolved and operational Congoleum asbestos trust fund has not been uniformly documented in the same manner as some other manufacturers’ trusts. Individuals with potential claims should consult with qualified asbestos litigation attorneys to determine the current status of any Congoleum-related bankruptcy trust or litigation avenues.

For workers and former workers who were exposed to Congoleum cushioned vinyl flooring and have received a diagnosis of an asbestos-related disease—including mesothelioma, asbestos-related lung cancer, asbestosis, or pleural disease—the following steps are advisable:

  • Consult a specialist attorney: Asbestos litigation attorneys can evaluate exposure histories, identify applicable defendants beyond Congoleum (including adhesive manufacturers, subcontractors, and premises owners), and determine viable legal strategies.
  • Document exposure history: Employment records, union membership records, coworker testimony, and product identification evidence are foundational to any claim.
  • Seek medical evaluation: A confirmed pathological or radiological diagnosis from a physician experienced in occupational lung disease is essential to any legal proceeding.
  • Investigate all exposure sources: Workers rarely encountered only one asbestos-containing product; a thorough occupational history may reveal additional liable parties and trust fund eligibility.

Litigation records document that plaintiffs alleging injury from Congoleum asbestos-containing flooring products have pursued claims in civil courts, with allegations centered on negligence, failure to warn, and product liability theories. Individuals with potential claims are encouraged to act promptly, as statutes of limitations vary by state and begin running from the date of diagnosis or the date a claimant knew or should have known of the connection between illness and asbestos exposure.